Arginase II Expressed in Cancer-Associated Fibroblasts Indicates Tissue Hypoxia and Predicts Poor Outcome in Patients with Pancreatic Cancer

Ino, Yoshinori; Yamazaki-Itoh, Rie; Oguro, Seiji; Shimada, Kazuaki; Kosuge, Tomoo; Zavada, Jan; Kanai, Yae; Hiraoka, Nobuyoshi
February 2013
PLoS ONE;Feb2013, Vol. 8 Issue 2, p1
Academic Journal
An adequate level of arginine in the tissue microenvironment is essential for T cell activity and survival. Arginine levels are regulated by the arginine-catabolizing enzyme, arginase (ARG). It has been reported that arginase II (ARG2), one of two ARGs, is aberrantly expressed in prostate cancer cells, which convert arginine into ornithine, resulting in a lack of arginine that weakens tumor-infiltrating lymphocytes and renders them dysfunctional. However, immune suppression mediated by ARG2-expressing cancer cells in lung cancer has not been observed. Here we studied the expression of ARG2 in pancreatic ductal carcinoma (PDC) tissue clinicopathologically by examining over 200 cases of PDC. In contrast to prostate cancer, ARG2 expression was rarely demonstrated in PDC cells by immunohistochemistry, and instead ARG2 was characteristically expressed in α-smooth muscle actin-positive cancer-associated fibroblasts (CAFs), especially those located within and around necrotic areas in PDC. The presence of ARG2-expressing CAFs was closely correlated with shorter overall survival (OS; P  = 0.003) and disease-free survival (DFS; P  = 0.0006). Multivariate Cox regression analysis showed that the presence of ARG2-expressing CAFs in PDC tissue was an independent predictor of poorer OS (hazard ratio [HR]  = 1.582, P  = 0.007) and DFS (HR  = 1.715, P  = 0.001) in PDC patients. In addition to the characteristic distribution of ARG2-expressing CAFs, such CAFs co-expressed carbonic anhydrase IX, SLC2A1, or HIF-1α, markers of hypoxia, in PDC tissue. Furthermore, in vitro experiments revealed that cultured fibroblasts extracted from PDC tissue expressed the ARG2 transcript after exposure to hypoxia, which had arginase activity. These results indicate that cancer cell-mediated immune suppression through ARG2 expression is not a general event and that the presence of ARG2-expressing CAFs is an indicator of poor prognosis, as well as hypoxia, in PDC tissue.


Related Articles

  • Hemoglobin level predicts outcome for vulvar cancer patients independent of GLUT-1 and CA-IX expression in tumor tissue. Nieuwenhof, Hedwig; Hullu, Joanne; Kaanders, Johannes; Bulten, Johan; Massuger, Leon; Kempen, Léon; van de Nieuwenhof, Hedwig P; de Hullu, Joanne A; Kaanders, Johannes H A M; Massuger, Leon F A G; van Kempen, Léon C L T // Virchows Archiv;Dec2010, Vol. 457 Issue 6, p693 

    Intratumoral hypoxia has been associated with poor prognosis in several solid tumors. The aim of this study was to determine whether the hypoxia-associated markers glucose transporter (GLUT)-1 and carbonic anhydrase (CA)-IX expression and preoperative hemoglobin (Hb) levels correlate with...

  • SOX9 regulates ERBB signalling in pancreatic cancer development. Grimont, Adrien; Pinho, Andreia V.; Cowley, Mark J.; Augereau, Cécile; Mawson, Amanda; Giry-Laterrière, Marc; Van den Steen, Géraldine; Waddell, Nicola; Pajic, Marina; Sempoux, Christine; Jianmin Wu; Grimmond, Sean M.; Biankin, Andrew V.; Lemaigre, Frédéric P.; Rooman, Ilse; Jacquemin, Patrick // Gut;Nov2015, Vol. 64 Issue 11, p1790 

    Objective: The transcription factor SOX9 was recently shown to stimulate ductal gene expression in pancreatic acinar-to-ductal metaplasia and to accelerate development of premalignant lesions preceding pancreatic ductal adenocarcinoma (PDAC). Here, we investigate how SOX9 operates in pancreatic...

  • Biological and Clinical Significance of MAD2L1 and BUB1, Genes Frequently Appearing in Expression Signatures for Breast Cancer Prognosis. Wang, Zhanwei; Katsaros, Dionyssios; Shen, Yi; Fu, Yuanyuan; Canuto, Emilie Marion; Benedetto, Chiara; Lu, Lingeng; Chu, Wen-Ming; Risch, Harvey A.; Yu, Herbert // PLoS ONE;8/19/2015, Vol. 10 Issue 8, p1 

    To investigate the biologic relevance and clinical implication of genes involved in multiple gene expression signatures for breast cancer prognosis, we identified 16 published gene expression signatures, and selected two genes, MAD2L1 and BUB1. These genes appeared in 5 signatures and were...

  • Circulating tumor cell detection and transcriptomic profiles in early breast cancer patients. Reyal, F.; Valet, F.; de Cremoux, P.; Mathiot, C.; Decraene, C.; Asselain, B.; Brain, E.; Delaloge, S.; Giacchetti, S.; Marty, M.; Pierga, J. Y.; Bidard, F. C. // Annals of Oncology;Jun2011, Vol. 22 Issue 6, p1458 

    No abstract available.

  • The expression level of miR-18b in hepatocellular carcinoma is associated with the grade of malignancy and prognosis. Murakami, Yoshiki; Tamori, Akihiro; Itami, Saori; Tanahashi, Toshihito; Toyoda, Hidenori; Tanaka, Masami; Weihong Wu; Brojigin, Nariso; Kaneoka, Yuji; Maeda, Atsuyuki; Kumada, Takashi; Kawada, Norifumi; Kubo, Shoji; Kuroda, Masahiko // BMC Cancer;2013, Vol. 13 Issue 1, p1 

    Background: Many studies support the hypothesis that specific microRNA (miRNA) expression in various human cancers including hepatocarcinogenesis is closely associated with diagnosis and prognosis. In hepatocellular carcinoma (HCC), malignancy level is related to the degree of histological...

  • Genistein downregulates onco-miR-1260b and inhibits Wnt-signalling in renal cancer cells. Hirata, H; Ueno, K; Nakajima, K; Tabatabai, Z L; Hinoda, Y; Ishii, N; Dahiya, R // British Journal of Cancer;5/21/2013, Vol. 108 Issue 10, p2070 

    Background:Wnt-signalling has an important role in renal cancer and it is modulated by genistein in other cancers. Recently, microRNAs (miRNAs) have emerged as new regulators of gene expression. Thus, we focused on miRNAs to examine the regulatory mechanism of genistein on the Wnt-signalling...

  • Gene expression profiling of melanoma cells -- searching the haystack. Brafford, Patricia; Herlyn, Meenhard // Journal of Translational Medicine;2005, Vol. 3, p2 

    Cancer is being increasingly recognized as a very heterogeneous disease, both within an individual tumor and within a tumor type and among tumor types. This heterogeneity is manifested both at the genetic and phenotypic level and determines the progression of disease and response to therapy. It...

  • P-0005 CLINICOPATHOLOGICAL SIGNIFICANCE OF EXPRESSION OF BECLIN1 AND P62 IN GASTRIC CANCER. Fei, Gu; Xin, Yan // Annals of Oncology;Jun2014, Vol. 25 Issue suppl_2, pii15 

    No abstract available.

  • Gene-expression data integration to squamous cell lung cancer subtypes reveals drug sensitivity. Wu, D; Pang, Y; Wilkerson, M D; Wang, D; Hammerman, P S; Liu, J S // British Journal of Cancer;9/17/2013, Vol. 109 Issue 6, p1599 

    Background:Squamous cell lung cancer (SqCC) is the second most common type of lung cancer in the United States. Previous studies have used gene-expression data to classify SqCC samples into four subtypes, including the primitive, classical, secretory and basal subtypes. These subtypes have...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics